http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3512854-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459549086df37b5bed0003502de7e7aa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
filingDate 2017-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84be94257298c343a85dc20d9dfe76dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5cf1be4ece765fac1cd7cc4d12db99e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7c923f8920071124e3e015420b386da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3a6cc434a2208519ab71e40ea25508
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff5429af211fcd0c14dc545b11a430bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fed0fdbef697f33f7a8448058eaad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_554340df0679749279a07a1be670ba6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c18db76fcbea2a4f6572714da3fd834e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33a0387b09df555839d564c4e1b85b38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ec1158637a75f058e149df11851593e
publicationDate 2019-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3512854-A1
titleOfInvention Process for the preparation of pure and stable crystalline raltegravir potassium form 3
abstract The present invention provides improved, commercially viable and consistently reproducible processes for the preparation of pure and stable crystalline Raltegravir potassium Form 3 and pharmaceutical composition thereof.
priorityDate 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227426690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435014
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54671008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54721841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057804

Total number of triples: 33.